Development of methodology for conducting clinical trials in frontotemporal lobar degeneration
Open accessThe DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Abstract
To design clinical trials for the frontotemporal lobar degenerations (FTLD), knowledge about measurement of disease progression is needed to estimate power and enable the choice of optimal outcome measures. The aim here was to conduct a multicentre, 1 year replica of a clinical trial in patients with one of four FTLD syndromes, behavioural variant frontotemporal dementia (bvFTD), progressive nonfluent aphasia (PNFA), progressive logopenic aphasia (PLA) and semantic dementia (SMD). Patients with one of the four FTLD syndromes were recruited from five academic medical centres over a 2 year period. Standard operationalized diagnostic criteria were used. In addition to clinical inclusion and exclusion criteria, patients were required to exhibit focal frontal, temporal or insular brain atrophy or dysfunction by neuroimaging. Patients underwent neuropsychological, functional, behavioural, neurological and MR imaging assessment at baseline and approximately 12 months later. Potential outcome measures were examined for their rates of floor and ceiling values at baseline and end of study, their mean changes and variances. The neuropsychological tests were combined into two cognitive composites -- one for language functions and the other for executive functions. There were 107 patients who underwent baseline assessment and 78 who completed a follow-up assessment within 10-16 months. Two global measures, the FTLD-modified Clinical Dementia Rating (FTLD-modified CDR) and the Clinical Global Impression of Change (CGIC) demonstrated decline in the majority of patients. Several cognitive measures showed negligible floor or ceiling scores either at baseline or follow-up. Scores declined at follow-up in the majority of patients. The cognitive, executive and combined composites were shown to be sensitive to change across all FTLD syndromes. Patients improved at follow-up on the behavioural scales -- the Frontal Behavioural Inventory (22%) and the Neuropsychiatric Inventory (28%) -- suggesting that these instruments may not be ideal for clinical trial use. It was feasible to recruit FTLD patients in a simulated multi-centre trial. There are several candidate outcome measures -- including the FTLD-CDR and the cognitive composites -- that could be used in clinical trials across the spectrum of FTLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Findings showed the FTLD-CDR demonstrated annual decline over years in genetic and sporadic FTD population (Knopman et al., 2008; Mioshi et al., 2017; Staffaroni et al., 2019a,b; Anderl-Straub et al., 2021; Lima-Silva et al., 2021).”
From The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials (2024) · cites this paper as Knopman et al., 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The adapted version of the CDR, FTLD-modified Clinical Dementia Rating scale (FTLD-CDR); (Knopman et al., 2008), added domains of language and behavior to the original scale, accounting for the most prominent symptoms in bvFTD (Knopman et al., 2011).”
From The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials (2024) · cites this paper as Knopman et al., 2008
In the citing paper
“Overall, literature demonstrated these measures can detect functional decline in bvFTD over extensive follow-up time (1–7 years) (Knopman et al., 2008; Mioshi and Hodges, 2009; O’Connor et al., 2016; Staffaroni et al., 2019b; Giebel et al., 2021).”
From The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials (2024) · cites this paper as Knopman et al., 2008
In the citing paper
“While one study did not report such behavioral inflection point during follow-up (Linds et al., 2015), the relative reduction of positive symptoms may show improvement of behavioral scores over time (Knopman et al., 2008).”
From The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials (2024) · cites this paper as Knopman et al., 2008
In the citing paper
“However, given cognitive heterogeneity, combining multiple test scores into (executive functioning, language and memory) composites is known to increase sensitivity to change and ability to detect annual decline in bvFTD (Knopman et al., 2008).”
From The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials (2024) · cites this paper as Knopman et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Validity of the Trail Making Test as an Indicator of Organic Brain Damage
Reitan, R. M. (1958) · Perceptual and Motor Skills · doi:10.2466/pms.1958.8.3.271 · Cited by 7,928
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Self-citationKaplan, E., Goodglass, H., Weıntraub, S., & Segal, O. (2001) · Medical Entomology and Zoology · Cited by 4,378
Research works printed but not linked: 3
- Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test. 2nd. San Antonio, TX: The Psychological Crop;; 2000. [Google Scholar]
- Sulestrowska, 1958, Medline Rows With NULL issns Will Point To This, 8, 271
- Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation; 1981. [Google Scholar]
Cited by
Items 101–200 of 442
Schroeter, M. L., Pawelke, S., Bisenius, S., Kynast, J., Schuemberg, K., Polyakova, M., Anderl‐Straub, S., Danek, A., Fassbender, K. C., Jahn, H., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00011 · Cited by 53
Biomarkers in frontotemporal lobar degenerations—Progress and challenges
Hu, W. T., Trojanowski, J. Q., & Shaw, L. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.04.012 · Cited by 42
“, 2010) Taking advantage of the within-individual rate of volume change (even when insufficiently sensitive or specific to syndrome or pathology), serial measurements of brain volume can be a potential biomarker of response in therapeutic trials once patients are categorized according to clinical syndrome, most domina…”
ResultJakabek, D., Power, B., Macfarlane, M. D., Walterfang, M., Velakoulis, D., van Westen, D., Lätt, J., Nilsson, M., Looi, J. C., & Santillo, A. F. (2018) · Human Brain Mapping · doi:10.1002/hbm.24233 · Cited by 43
Rofes, A., de Aguiar, V., Ficek, B., Wendt, H., Webster, K. T., & Tsapkini, K. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180990 · Cited by 48
Strikwerda‐Brown, C., Ramanan, S., Goldberg, Z.-L., Mothakunnel, A., Hodges, J. R., Ahmed, R. M., Piguet, O., & Irish, M. (2020) · Brain · doi:10.1093/brain/awaa435 · Cited by 47
Themistocleous, C., Webster, K., Afthinos, A., & Tsapkini, K. (2021) · American Journal of Speech-Language Pathology · doi:10.1044/2020_ajslp-19-00114 · Cited by 41
Revised Self-Monitoring Scale: A potential endpoint for frontotemporal dementia clinical trials
Toller, G., Ranasinghe, K., Cobigo, Y., Staffaroni, A., Appleby, B., Brushaber, D., Coppola, G., Dickerson, B., Domoto-Reilly, K., Fields, J., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009451 · Cited by 40
“We have recently shown that the RSMS shows high interindividual variability and is not susceptible to ceiling or floor effects, both in healthy participants across the lifespan and in patients with neurodegenerative disease,(9) psychometric qualities that are required for measures to be used to assess symptom progress…”
BackgroundSelf-citationIndividualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration
Staffaroni, A. M., Cobigo, Y., Goh, S. M., Kornak, J., Bajorek, L., Chiang, K., Appleby, B., Bove, J., Bordelon, Y., Brannelly, P., et al. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.04.007 · Cited by 40
Self-citationMapping brain morphological and functional conversion patterns in predementia late-onset bvFTD
Morbelli, S., Ferrara, M., Fiz, F., Dessi, B., Arnaldi, D., Picco, A., Bossert, I., Buschiazzo, A., Accardo, J., Picori, L., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3335-3 · Cited by 40
Nunes, P. V., Schwarzer, M. C., Leite, R. E. P., Ferretti‐Rebustini, R. E. D. L., Pasqualucci, C. A., Nitríni, R., Rodriguez, R. D., Nascimento, C. F., de Oliveira, K. C., Grinberg, L. T., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180641 · Cited by 45
A transdiagnostic review of neuroimaging studies of apathy and disinhibition in dementia
Jenkins, L. M., Wang, L., Rosen, H. J., & Weıntraub, S. (2022) · Brain · doi:10.1093/brain/awac133 · Cited by 51
Kim, E., Kim, Y.-E., Jang, J., Cho, E., Na, D. L., Seo, S. W., Jung, N., Jeong, J. H., Kwon, J. C., Park, K. H., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.031 · Cited by 43
Franzen, S., Nuytemans, K., Bourdage, R., Caramelli, P., Ellajosyula, R., Finger, E. C., Illán‐Gala, I., Loi, S. M., Morhardt, D., Pijnenburg, Y. A. L., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13129 · Cited by 39
The Speech and Language FOXP2 Gene Modulates the Phenotype of Frontotemporal Lobar Degeneration
Padovani, A., Cosseddu, M., Premi, E., Archetti, S., Papetti, A., Agosti, C., Bigni, B., Cerini, C., Paghera, B., Bellelli, G., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101206 · Cited by 40
Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia
Panman, J. L., Venkatraghavan, V., van der Ende, E. L., Steketee, R. M. E., Jiskoot, L. C., Poos, J. M., Dopper, E. G. P., Meeter, L. H. H., Donker Kaat, L., Rombouts, S. A. R. B., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323541 · Cited by 38
Quantifying progression in primary progressive aphasia with structural neuroimaging
Lombardi, J., Mayer, B., Semler, E., Anderl‐Straub, S., Uttner, I., Kassubek, J., Diehl‐Schmid, J., Danek, A., Levin, J., Fassbender, K. C., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12323 · Cited by 38
Sablonnière, J. D. L., Tastevin, M., Lavoie, M., & Laforce, R. J. (2021) · Brain Sciences · doi:10.3390/brainsci11091209 · Cited by 41
Non-Pharmacological Management for Patients with Frontotemporal Dementia: A Systematic Review
Shinagawa, S., Nakajima, S., Plitman, E., Graff‐Guerrero, A., Mimura, M., Nakayama, K., & Miller, B. L. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142109 · Cited by 45
Self-citationEffects of tDCS on Sound Duration in Patients with Apraxia of Speech in Primary Progressive Aphasia
Themistocleous, C. K., Webster, K. T., & Tsapkini, K. (2021) · Brain Sciences · doi:10.3390/brainsci11030335 · Cited by 40
Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates
Borroni, B., Cosseddu, M., Pilotto, A., Premi, E., Archetti, S., Gasparotti, R., Cappa, S. F., & Padovani, A. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.07.019 · Cited by 40
Amyloid beta in nasal secretions may be a potential biomarker of Alzheimer’s disease
Kim, Y. H., Lee, S.-M., Cho, S., Kang, J., Minn, Y., Park, H., & Choi, S. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-41429-1 · Cited by 40
Shiells, H., Schelter, B. O., Bentham, P., Baddeley, T. C., Rubino, C. M., Ganesan, H., Hammel, J., Vuksanović, V., Staff, R. T., Murray, A. D., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191173 · Cited by 35
Disease progression in C9orf72 mutation carriers
Floeter, M. K., Traynor, B. J., Farren, J., Braun, L. E., Tierney, M., Wiggs, E. A., & Wu, T. (2017) · Neurology · doi:10.1212/wnl.0000000000004115 · Cited by 39
The Assessment of Language and Communication in Dementia: A Synthesis of Evidence
Krein, L., Jeon, Y., Amberber, A. M., & Fethney, J. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.11.009 · Cited by 43
Uniform data set language measures for bvFTD and PPA diagnosis and monitoring
Staffaroni, A. M., Weintraub, S., Rascovsky, K., Rankin, K. P., Taylor, J., Fields, J. A., Casaletto, K. B., Hillis, A. E., Lukic, S., Gorno‐Tempini, M. L., et al. (2021) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12148 · Cited by 33
Self-citationAlberici, A., Archetti, S., Pilotto, A., Premi, E., Cosseddu, M., Bianchetti, A., Semeraro, F., Salvetti, M., Muiesan, M. L., Padovani, A., et al. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1683-y · Cited by 36
Quantitating Severity and Progression in Primary Progressive Aphasia
Dickerson, B. C. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9534-2 · Cited by 39
[18F]-THK5351 PET Imaging in Patients With Semantic Variant Primary Progressive Aphasia
Lee, H., Seo, S., Lee, S., Jeong, H. J., Woo, S., Lee, K., Lee, Y., Park, K. H., Heo, J., Yoon, C. W., et al. (2017) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000216 · Cited by 35
Transition of Distinctive Symptoms of Semantic Dementia during Longitudinal Clinical Observation
Kashibayashi, T., Ikeda, M., Komori, K., Shinagawa, S., Shimizu, H., Toyota, Y., Mori, T., Ishikawa, T., Fukuhara, R., Ueno, S., et al. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000269972 · Cited by 38
Monitoring Progression of Primary Progressive Aphasia: Current Approaches and Future Directions
Sapolsky, D., Domoto‐Reilly, K., Negreira, A. M., Brickhouse, M. J., McGinnis, S. M., & Dickerson, B. C. (2011) · Neurodegenerative Disease Management · doi:10.2217/nmt.11.2 · Cited by 32
Brain volumetric deficits in MAPT mutation carriers: a multisite study
Chu, S. A., Flagan, T., Staffaroni, A. M., Jiskoot, L. C., Deng, J., Spina, S., Zhang, L., Sturm, V. E., Yokoyama, J. S., Seeley, W. W., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51249 · Cited by 32
Self-citationTao, Y., Ficek, B., Wang, Z., Rapp, B. C., & Tsapkini, K. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.681043 · Cited by 35
Benussi, A., Huber, H., Tan, K., Cantoni, V., Rivolta, J., Cotelli, M. S., Benedet, A. L., Blennow, K., Zetterberg, H., Ashton, N. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14482 · Cited by 39
Spotorno, N., Lindberg, O. E., Nilsson, C., Waldö, M. L., van Westen, D., Nilsson, K., Vestberg, S., Englund, E. M., Zetterberg, H., Blennow, K., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236384 · Cited by 33
Phillips, J. S., Nitchie, F. J., Re, F. D., Olm, C. A., Cook, P. A., McMillan, C. T., Irwin, D. J., Gee, J. C., Dubroff, J. G., Grossman, M., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12456 · Cited by 34
Ljubenkov, P. A., Edwards, L., Iaccarino, L., La Joie, R., Rojas, J. C., Koestler, M., Harris, B., Boeve, B. F., Borroni, B., van Swieten, J. C., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.25584 · Cited by 30
Self-citationDetecting clinical change with the CDR-FTLD: differences between FTLD and AD dementia
Mioshi, E., Flanagan, E., & Knopman, D. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4556 · Cited by 29
“The Clinical Dementia Rating - FTLD scale-modified (CDR-FTLD) (Knopman et al., 2008) addresses this issue with the addition of two extra domains, language and behaviour, making it more sensitive to FTLD subtypes, while enhancing description of disease # 2016 The Authors.”
MethodSelf-citationMaiovis, P., Ioannidis, P., Gerasimou, G., Psarrakou, A. G., & Karacostas, D. (2018) · Neurodegenerative Diseases · doi:10.1159/000486621 · Cited by 32
Cousins, K. A. Q., Ash, S., Olm, C. A., & Grossman, M. (2018) · eneuro · doi:10.1523/eneuro.0197-18.2018 · Cited by 30
“Patients were native speakers of English, and matched for age, education, FTLD clinical dementia rating sum of boxes (FTLD-CDR SoB; Knopman et al., 2008), mini-mental state examination (MMSE; Folstein et al., 1975), and disease duration at time 1 (Table 1), determined by independent t tests.”
MethodSpinelli, E. G., Ghirelli, A., Basaia, S., Cividini, C., Riva, N., Canu, E., Castelnovo, V., Domi, T., Magnani, G., Caso, F., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012702 · Cited by 32
Dysfunction of Social Cognition and Behavior
Dickerson, B. C. (2015) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000466659.05156.1d · Cited by 37
Gonçalves, S. D. A. B., Caramelli, P., Mariano, L. I., Guimarães, H. C., Gambogi, L. B., Resende, E. D. P. F., Teixeira, A. L., & de Souza, L. C. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146799 · Cited by 29
Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia
Barker, M. S., Manoochehri, M., Rizer, S. J., Appleby, B. S., Brushaber, D., Dev, S. I., Devick, K. L., Dickerson, B. C., Fields, J. A., Foroud, T. M., et al. (2021) · Cortex · doi:10.1016/j.cortex.2021.03.006 · Cited by 29
Self-citationWhitwell, J. L., Lowe, V. J., Duffy, J. R., Strand, E. A., Machulda, M. M., Kantarci, K., Wille, S. M., Senjem, M. L., Murphy, M. C., Gunter, J. L., et al. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305628 · Cited by 29
Wilson, N., Ramanan, S., Roquet, D., Goldberg, Z.-L., Hodges, J. R., Piguet, O., & Irish, M. (2019) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2019.107327 · Cited by 32
The effect of semantic memory degeneration on creative thinking: A voxel-based morphometry analysis
Paulin, T., Roquet, D., Kenett, Y. N., Savage, G. R., & Irish, M. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117073 · Cited by 38
Riello, M., Faria, A. V., Ficek, B., Webster, K., Onyike, C. U., Desmond, J., Frangakis, C., & Tsapkini, K. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00346 · Cited by 29
Reliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar Degeneration
Staffaroni, A. M., Clark, A. L., Taylor, J. C., Heuer, H. W., Sanderson-Cimino, M., Wise, A. B., Dhanam, S., Cobigo, Y., Wolf, A., Manoochehri, M., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.4266 · Cited by 28
Self-citationNeophytou, K., Wiley, R. W., Rapp, B. C., & Tsapkini, K. (2019) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2019.107157 · Cited by 29
Mapping behavioural, cognitive and affective transdiagnostic dimensions in frontotemporal dementia
Ramanan, S., El-Omar, H., Roquet, D., Ahmed, R. M., Hodges, J. R., Piguet, O., Ralph, M. A. L., & Irish, M. (2022) · Brain Communications · doi:10.1093/braincomms/fcac344 · Cited by 30
Automated semantic indices related to cognitive function and rate of cognitive decline
Pakhomov, S., Hemmy, L. S., & Lim, K. O. (2012) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2012.05.016 · Cited by 38
O'Connor, C. M., Clemson, L., Brodaty, H., Jeon, Y. H., Mioshi, E., & Gitlin, L. N. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214000040 · Cited by 27
Slachevsky, A., Pedro Zitko, M., Martínez‐Pernía, D., Forno, G., Court, F. A., Lillo, P., Villagra, R., Duran-Aniotz, C. A., Parrao, T., Assar, R., et al. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01866-4 · Cited by 31
Prodromal frontotemporal dementia: clinical features and predictors of progression
Benussi, A., Ashton, N. J., Karikari, T. K., Alberici, A., Saraceno, C., Ghidoni, R., Benussi, L., Zetterberg, H., Blennow, K., & Borroni, B. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00932-2 · Cited by 26
TOMM40, APOE, and APOC1 in Primary Progressive Aphasia and Frontotemporal Dementia
Seripa, D., Bizzarro, A., Pilotto, A., Palmieri, O., Panza, F., D’Onofrio, G., Gravina, C., Archetti, S., Daniele, A., Borroni, B., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120403 · Cited by 27
Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis
Saxon, J. A., Thompson, J. C., Harris, J., Richardson, A. M. T., Langheinrich, T., Rollinson, S. J., Pickering-Brown, S. M., Chaouch, A., Ealing, J., Hamdalla, H. H. M., et al. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323969 · Cited by 30
Looking for measures of disease severity in the frontotemporal dementia continuum
Premi, E., Gualeni, V., Costa, P., Cosseddu, M., Gasparotti, R., Padovani, A., & Borroni, B. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160178 · Cited by 26
“In FTD, to overcome the heterogeneous picture [2, 6, 7], the Clinical Dementia Rating for FTD (FTLD-modified CDR) has been developed, considering behavioral disturbances and language impairment as additional items to the CDR scale [8].”
InfluentialLicata, A. E., Zhao, Y., Herrmann, O., Hillis, A. E., Desmond, J. E., Onyike, C. U., & Tsapkini, K. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103329 · Cited by 27
Sustained attention failures on a 3-min reaction time task is a sensitive marker of dementia
Manuel, A. L., Foxe, D., Bradshaw, N., Cordato, N. J., Hodges, J. R., Burrell, J. R., & Piguet, O. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09261-9 · Cited by 26
Unal, G., Ficek, B., Webster, K. T., Shahabuddin, S., Truong, D. Q., Hampstead, B. M., Bikson, M., & Tsapkini, K. (2020) · Neurological Sciences · doi:10.1007/s10072-019-04229-z · Cited by 30
The contribution of behavioral features to caregiver burden in FTLD spectrum disorders
Silverman, H. E., Ake, J. M., Manoochehri, M., Appleby, B. S., Brushaber, D. E., Devick, K. L., Dickerson, B. C., Fields, J. A., Forsberg, L. K., Ghoshal, N., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12494 · Cited by 24
Self-citationCasaletto, K. B., Kornack, J., Paolillo, E. W., Rojas, J. C., VandeBunte, A. M., Staffaroni, A. S., Lee, S. Y., Heuer, H. W., Forsberg, L. K., Ramos, E. M., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.4178 · Cited by 27
Self-citationNeurophysiological Correlates of Positive and Negative Symptoms in Frontotemporal Dementia
Benussi, A., Dell’Era, V., Cantoni, V., Cotelli, M. S., Cosseddu, M., Spallazzi, M., Alberici, A., Padovani, A., & Borroni, B. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190986 · Cited by 33
Intrahepatic cholestasis due to systemic mastocytosis: a case report and review of literature.
Safyan, E. L., Veerabagu, M. P., Swerdlow, S. H., Lee, R. G., & Rakela, J. L. (1997) · PubMed · Cited by 29
The Cortical Basal ganglia Functional Scale (CBFS): Development and preliminary validation
Lang, A. E., Stebbins, G. T., Wang, P., Jabbari, E., Lamb, R., Morris, H. R., Boxer, A. L., Boxer, A. L., Boeve, B. F., Dickerson, B. C., et al. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.08.021 · Cited by 27
Self-citationCortical microstructure in primary progressive aphasia: a multicenter study
Illán‐Gala, I., Montal, V., Borrego‐Écija, S., Mandelli, M. L., Falgàs, N., Welch, A. E., Pegueroles, J., Santos‐Santos, M., Bejanin, A., Alcolea, D. A., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00974-0 · Cited by 29
Self-citationBilingual Primary Progressive Aphasia: A Scoping Review of Assessment and Treatment Practices
Grasso, S. M., Rodríguez, C. A. W., Colomer, N. M., Marques‐Kiderle, S. K., Sánchez‐Valle, R., & Santos‐Santos, M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230673 · Cited by 34
The case of a 48 year-old woman with bizarre and complex delusions
Loy, C. T., Kril, J. J., Trollor, J. N., Kiernan, M. C., Kwok, J. B., Vucic, S., Halliday, G. M., & Hodges, J. R. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.3 · Cited by 25
Data-driven regions of interest for longitudinal change in frontotemporal lobar degeneration
Pankov, A., Binney, R. J., Staffaroni, A. M., Kornak, J., Attygalle, S., Schuff, N., Weiner, M. W., Kramer, J. H., Dickerson, B. C., Miller, B. L., et al. (2016) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.08.002 · Cited by 24
Self-citationRamanan, S., Marstaller, L., Hodges, J. R., Piguet, O., & Irish, M. (2020) · Cortex · doi:10.1016/j.cortex.2019.12.026 · Cited by 27
Ye, B. S., Choi, S. H., Han, S.-H., Kim, S., Yang, D.-W., Park, K. H., Han, H. J., Youn, Y. C., Choi, B.-O., Kim, S. H., et al. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-141044 · Cited by 24
Clinical characteristics of parkinsonism in frontotemporal dementia according to subtypes
Park, H. K., Park, K. H., Yoon, B., Lee, J.-H., Choi, S. H., Joung, J. H., Yoon, S. J., Kim, B. C., Kim, S. H., Kim, E.-J., et al. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.11.033 · Cited by 24
“The Clinical Evaluation Form included: (1) history of cognitive decline by the caregiver, (2) the Korean version of Mini-Mental State Examination (K-MMSE) [21], (3) the FTLD-CDR sum of boxes (FTLD-CDR SB) score [19], (4) CDR-SB, (5) the Geriatric Depression Scale (GDS) [22], (6) UPDRS III score [18], and (7) a neurolo…”
InfluentialFunctional Connectivity From Disease Epicenters in Frontotemporal Dementia
Agosta, F., Spinelli, E. G., Basaia, S., Cividini, C., Falbo, F., Pavone, C., Riva, N., Canu, E., Castelnovo, V., Magnani, G., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207277 · Cited by 24
Interhemispheric Differences in Knowledge of Animals Among Patients With Semantic Dementia
Mendez, M. F., Kremen, S. A., Tsai, P., & Shapira, J. S. (2010) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e3181f22448 · Cited by 25
Self-citationClinical value of cerebrospinal fluid neurofilament light chain in semantic dementia
Meeter, L. H. H., Steketee, R. M. E., Salkovic, D., Vos, M. E., Grossman, M., McMillan, C. T., Irwin, D. J., Boxer, A. L., Rojas, J. C., Olney, N. T., et al. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-319784 · Cited by 24
Self-citationFoxe, D., Irish, M., Roquet, D., Scharfenberg, A., Bradshaw, N., Hodges, J. R., Burrell, J. R., & Piguet, O. (2020) · Cortex · doi:10.1016/j.cortex.2020.08.018 · Cited by 25
Semantic knowledge of social interactions is mediated by the hedonic evaluation system in the brain
Rijpma, M. G., Montembeault, M., Shdo, S. M., Kramer, J. H., Miller, B. L., & Rankin, K. P. (2023) · Cortex · doi:10.1016/j.cortex.2022.12.015 · Cited by 22
Self-citationDemencia frontotemporal variante conductual: aproximación clínica y terapéutica
Fernández‐Matarrubia, M., Matías‐Guiu, J. A., Moreno‐Ramos, T., & Matías‐Guiu, J. (2013) · Neurología · doi:10.1016/j.nrl.2013.03.001 · Cited by 29
A computerized technique to assess language use patterns in patients with frontotemporal dementia
Pakhomov, S., Smith, G. E., Marino, S. E., Birnbaum, A. K., Graff‐Radford, N. R., Caselli, R. J., Boeve, B. F., & Knopman, D. S. (2010) · Journal of Neurolinguistics · doi:10.1016/j.jneuroling.2009.12.001 · Cited by 35
Self-citationBinney, R. J., Pankov, A., Marx, G., He, X., McKenna, F., Staffaroni, A. M., Kornak, J., Attygalle, S., Boxer, A. L., Schuff, N., et al. (2017) · Brain and Behavior · doi:10.1002/brb3.675 · Cited by 21
Self-citationRandomized controlled trials in frontotemporal dementia: cognitive and behavioral outcomes
Miller, J. B., Banks, S. J., Léger, G. C., & Cummings, J. L. (2014) · Translational Neurodegeneration · doi:10.1186/2047-9158-3-12 · Cited by 23
Neural Correlates of Letter and Semantic Fluency in Primary Progressive Aphasia
Riello, M., Frangakis, C., Ficek, B., Webster, K. T., Desmond, J. E., Faria, A. V., Hillis, A. E., & Tsapkini, K. (2021) · Brain Sciences · doi:10.3390/brainsci12010001 · Cited by 28
Ding, W., Ren, P., Yi, L., Si, Y., Yang, F., Li, Z., Bao, H., Yan, S., Zhang, X., Li, S., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01208-7 · Cited by 22
Self-citationKim, E., Park, K.-W., Lee, J., Choi, S.-H., Jeong, J. H., Yoon, S. J., Kim, B. C., Kwon, J. C., Ku, B. D., Kim, S. H., et al. (2014) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000360278 · Cited by 25
Lifting the veil: how to use clinical neuropsychology to assess dementia
Burrell, J. R., & Piguet, O. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-307483 · Cited by 30
Grey and White Matter Clinico-Anatomical Correlates of Disinhibition in Neurodegenerative Disease
Santillo, A. F., Lundblad, K., Nilsson, M., Waldö, M. L., van Westen, D., Lätt, J., Nordström, E., Vestberg, S., Lindberg, O. E., & Nilsson, C. F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164122 · Cited by 23
Kim, A., Kim, S., Park, K. W., Park, K. H., Youn, Y. C., Lee, D. W., Lee, J., Lee, J. H., Jeong, J. H., Choi, S. H., et al. (2019) · Journal of Korean Medical Science · doi:10.3346/jkms.2019.34.e111 · Cited by 24
Predictors of survival in frontotemporal lobar degeneration syndromes
El‐Wahsh, S., Finger, E. C., Piguet, O., Mok, V., Rohrer, J. D., Kiernan, M. C., & Ahmed, R. M. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-324349 · Cited by 22
Midorikawa, A., Leyton, C. E., Foxe, D., Landin-Romero, R., Hodges, J. R., & Piguet, O. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160440 · Cited by 20
“Two-hundred-and-sixty-one caregivers of patients with dementia were contacted by mail and sent the HSS questionnaire as well as the frontotemporal lobar dementia-modified Clinical Dementia Rating (FTLD-modified CDR) [22], in order to establish disease severity, of whom 160 returned the questionnaire (61.”
MethodTaylor, J. C., Heuer, H. W., Clark, A. L., Wise, A. B., Manoochehri, M., Forsberg, L., Mester, C., Rao, M., Brushaber, D., Kramer, J., et al. (2023) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12423 · Cited by 20
Self-citationManuel, A. L., Roquet, D., Landín-Romero, R., Kumfor, F., Ahmed, R. M., Hodges, J. R., & Piguet, O. (2020) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsaa085 · Cited by 22
Lindbergh, C. A., Hillblom Aging Network, Casaletto, K. B., Staffaroni, A. M., Joie, R. L., Iaccarino, L., Edwards, L., Tsoy, E., Elahi, F. M., Walters, S. M., et al. (2020) · Neuropsychology · doi:10.1037/neu0000696 · Cited by 21
Self-citationWang, Z., Ficek, B., Webster, K. T., Herrmann, O., Frangakis, C., Desmond, J. E., Onyike, C. U., Caffo, B. S., Hillis, A. E., & Tsapkini, K. (2022) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2022.09.004 · Cited by 25
Tosun, D., Rosen, H. J., Miller, B. L., Weiner, M. W., & Schuff, N. W. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.10.031 · Cited by 22
Self-citationAre we comparing frontotemporal dementia and Alzheimer disease patients with the right measures?
Deutsch, M. B., Liang, L.-J. F., Jimenez, E. E., Mather, M. J., & Mendez, M. F. (2016) · International Psychogeriatrics · doi:10.1017/s1041610216000582 · Cited by 20
Self-citationMassimo, L. M., Xie, S. X., Rennert, L., Fick, D. M., Halpin, A., Placek, K., Williams, A., Rascovsky, K., Irwin, D. J., Grossman, M., et al. (2018) · Brain Imaging and Behavior · doi:10.1007/s11682-018-9852-x · Cited by 23
Son, H. J., Oh, J. S., Roh, J. H., Seo, S. W., Oh, M., Lee, S. J., Oh, S. J., & Kim, J. S. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4125-x · Cited by 21
Frontal lobe 1 H MR spectroscopy in asymptomatic and symptomatic MAPT mutation carriers
Chen, Q., Boeve, B. F., Tosakulwong, N., Lesnick, T. G., Brushaber, D. E., Dheel, C. M., Fields, J. A., Forsberg, L. K., Gavrilova, R. H., Gearhart, D. J., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007961 · Cited by 21
Self-citationTracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers
Chen, Q., Boeve, B. F., Schwarz, C. G., Reid, R. I., Tosakulwong, N., Lesnick, T. G., Bove, J., Brannelly, P., Brushaber, D. E., Coppola, G., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.011 · Cited by 21
Self-citationFunctional disability in primary progressive aphasia
O’Connor, C. M. C., Ahmed, S., & Mioshi, E. (2014) · Aphasiology · doi:10.1080/02687038.2014.910588 · Cited by 25
Metadata
- Authors
- Knopman, D. S., Kramer, J. H., Boeve, B. F., Caselli, R. J., Graff-Radford, N. R., Mendez, M. F., Miller, B. L., & Mercaldo, N.
- Affiliations
- Mayo Clinic (US)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-06-21
- Volume
- 131
- Issue
- 11
- Pages
- 2957-2968
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC2725027
- OpenAlex
- W1984148891
- Cited by
- 442
- References
- 48
- Citations by year
- 2026: 25 · 2025: 31 · 2024: 36 · 2023: 28 · 2022: 30 · 2021: 41 · 2020: 49 · 2019: 36 · 2018: 26 · 2017: 13 · 2016: 20 · 2015: 17 · 2014: 21 · 2013: 20 · 2012: 14
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P30-AG-19610, P50‐AG16574, U01AG016976, P50AG016570, P30AG019610, R01AG023195, P01AG019724, P50AG023501, P50AG016574)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- frontotemporal lobar degeneration, clinical trial design, outcome measures, disease progression, behavioral variant frontotemporal dementia, progressive nonfluent aphasia, semantic dementia, neuropsychological assessment, Clinical Global Impression of Change, Neuropsychiatric Inventory, floor and ceiling effects, language loss, executive function decline
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aphasia, Cognition Disorders, Dementia, Female, Humans, Longitudinal Studies, Male, Middle Aged, Neuropsychological Tests, Psychiatric Status Rating Scales, Research Design, Randomized Controlled Trials as Topic, Outcome Assessment, Health Care, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.